Author:
Ciudad J.,San Miguel J. F.,Lopez-Berges M. C.,Valverde B.,Vidriales B.,Loperz A. M. A.,Gonzalez M.,Garcia-Sanz R.,Orfao A.
Publisher
Springer Berlin Heidelberg
Reference36 articles.
1. Campana D, E. Coustan-Smith, F.G. Behm. The definition of remission in acute leukemia with immunologic techniques. Bone Marrow Transpl 1991; 8: 429–37.
2. van Dongen JJM, T.M. Briet, H.J. Adriaasen, A. Beishuizen, H. Hooijkaas. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6(suppl 1): 47–59.
3. Lange BJ, G. Rovera. Detection of minimal residual leukemia in acute lymphoblastic leukemia. Hematol/Oncol Clin Am 1990; 4: 895–914.
4. Hooijkaas H, K. Hahlen, H.J. Adraasen, I. Dekker, G.E. van Zaden, J.J.M. van Dongen (1989) Terminal deoxynucleotidyl transferase positive cells in cerebrospinal fluid and development of overt CNS leukemia: a 5-year follow-up study in 113 children with Tdt positive leukemia or non-Hodgkin’s lymphoma. Blood, 74, 416–21.
5. Hagenbeek A, A.C.M. Maertens. Minimal residual disease in acute leukemia: preclinical studies in a relevant rat model (BNML). Bailliere’s Clin Hematol 1991; 4: 609–635.